Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Sernova Corp > Wow! What a news release
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by clutchbeyerson Mar 23, 2021 8:13pm
148 Views
Post# 32863160

RE:RE:RE:RE:RE:RE:RE:Wow! What a news release

RE:RE:RE:RE:RE:RE:RE:Wow! What a news release
Metalsguy1 wrote:
Red. Who said anything about sentiments turning south. It was woundedstooge who suggested that criticizing a news release constituted bashing the company. The news release was fluff and does nothing in my opinion except to ask what or who does it serve. Every last resource and every bit of management's attention should be focused on getting a deal signed that they can announce, getting the last two patients implanted, and showing measurable progress in all other indications. There was hardly anything new in the big update. All the fluff pieces in the world may make you feel food but they don't to anything in terms of advancing the primary goals.


Wen moon x40 overnight? Want Dr to sell now, need make money. No stimulus. Me mad.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities